ORIGINAL RESEARCH article
Front. Immunol.
Sec. Nutritional Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1587426
This article is part of the Research TopicEffects of Plant-Derived Bioactive Compounds as Nutritional Supplements on InflammationView all 4 articles
Oligosaccharides from the seeds of Dolichos lablab L. promote gut microbial metabolite L-arginine production to alleviate cyclophosphamide-induced immunosuppression
Provisionally accepted- 1School of Pharmacy, Binzhou Medical University, Yantai, China
- 2Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, China
- 3The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Yantai, Shandong Province, China
- 4Yantai Hospital of Traditional Chinese Medicine, Binzhou Medical University, Yantai, China
- 5Binzhou Medical University, Yantai Hospital of Traditional Chinese Medicine, Yantai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Dolichos lablab L. possesses significant nutritional and medicinal value. However, research on its oligosaccharides remains limited. This study investigated the effects of Dolichos lablab L. oligosaccharides on cyclophosphamide (CTX)-induced immunosuppression in mice. The crude oligosaccharides were purified to obtain a mixture named SRSV with an increased sugar content of 86%. The major components include sucrose, raffinose, stachyose, and verbascose at mass ratios of 19:16.8:50:14.2. SRSV (150mg/kg) preserves intestinal villi integrity, reverses CTX-induced immune organ atrophy, and restores the CD4+T/CD8+T ratio. It enhances bone marrow hematopoiesis, increases white blood cell and lymphocyte counts, and modulates blood TNF-α to ameliorate CTX-induced immunosuppression. 16S rRNA sequencing reveals that SRSV increases gut microbiota (GM) diversity, promoting beneficial bacteria like Ruminococcus, UBA1819, and Anaerofustis, while reducing pathogenic Atopobiaceae. Antibiotic-induced GM depletion significantly reduces SRSV’s protective effects, highlighting GM’s critical role. Metabolomics analysis identifies L-arginine as a key metabolite, enriched in the arginine biosynthesis pathway. Feeding L-arginine alone reproduces SRSV’s immune-protective effects in immunosuppressed mice. These findings indicate that SRSV has the potential to alleviate chemotherapy-induced immunosuppression and intestinal damage, positioning it as a promising immune enhancer and natural adjuvant for chemotherapy.
Keywords: Dolichos lablab L., oligosaccharide, gut microbiome, Prebiotics, Immunosuppression, chemotherapy
Received: 04 Mar 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 Liu, Jin, Zhou, Shang, Meng, Du, Geng, Gao, Zhao, Su and Pan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiaohong Pan, School of Pharmacy, Binzhou Medical University, Yantai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.